SCHEMBL5775124

SCHEMBL5775124

COC(=O)N1CCc2cc(/C=C/c3ccc4cc(/C(N)=N\O)ccc4c3)ccc2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TMPRSS2 O15393 3/20 0.43
PLAU P00749 3/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
HDAC6 Q9UBN7 5/20 0.40
HDAC8 Q9BY41 2/20 0.40
ABHD6 Q9BV23 1/20 0.39
HDAC1 Q13547 2/20 0.38
HDAC3 O15379 1/20 0.38
ESR2 Q92731 2/20 0.38
MAPK1 P28482 1/20 0.38
ESR1 P03372 1/20 0.38
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
KDM1A O60341 1/20 0.36
BCHE P06276 1/20 0.36
MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5775126 1.00 TMPRSS2 (0.43) TMPRSS2PLAUCA1CA2CA7
SCHEMBL5776273 0.89 PLAU (0.43) TMPRSS2PLAUCA1CA2CA7
SCHEMBL5776279 0.89 PLAU (0.43) TMPRSS2PLAUCA1CA2CA7
SCHEMBL5778274 0.79 MAPT (0.45) ABHD6HDAC1ESR2ESR1MEN1
SCHEMBL5778278 0.79 MAPT (0.45) ABHD6HDAC1ESR2ESR1MEN1
SCHEMBL5779869 0.76 PLAU (0.57) TMPRSS2PLAU
SCHEMBL5779866 0.76 PLAU (0.57) TMPRSS2PLAU
SCHEMBL2602112 0.75 ESR2 (0.65) TMPRSS2CA1CA2CA7CA9
SCHEMBL5776285 0.73 TMPRSS2 (0.45) TMPRSS2PLAUHDAC6HDAC8HDAC1
SCHEMBL5776142 0.72 PLAU (0.74) PLAUKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6504031-B1 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents ABBOTT LABORATORIES 2003-01-07 US claimed
US-6495562-B1 SUCH AS 6-(2-(4,4-DIETHYL-1-ISOPROPYL-3,4-DIHYDRO-6-ISOQUINOLINYL)CYCLOPROPYL)-2 -NAPHTHALENECARBOXIMIDAMIDE ABBOTT LABORATORIES 2002-12-17 US claimed
EP-1276722-B1 NAPHTHAMIDINE UROKINASE INHIBITORS ABBOTT LAB (US) 2006-03-08 EP disclosed
EP-1276722-A1 NAPHTHAMIDINE UROKINASE INHIBITORS Abbott Laboratories (US) 2003-01-22 EP disclosed
US-6504031-B1 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents ABBOTT LABORATORIES 2003-01-07 US disclosed
US-6495562-B1 SUCH AS 6-(2-(4,4-DIETHYL-1-ISOPROPYL-3,4-DIHYDRO-6-ISOQUINOLINYL)CYCLOPROPYL)-2 -NAPHTHALENECARBOXIMIDAMIDE ABBOTT LABORATORIES 2002-12-17 US disclosed
WO-2001081314-A1 NAPHTHAMIDINE UROKINASE INHIBITORS ABBOTT LABORATORIES (US) 2001-11-01 WO disclosed